Company | France

Primary tabs

About your organization

Phoenicis start-up company is focused on the development of an innovative disease-modifying candidate targeting a key enzyme involved in inflammatory processes: the myeloperoxydase (MPO), already clinically validated in diverse severe conditions. The vision of Phoenicis is to develop its lead candidate in diverse relevant indications characterized by high unmet needs after the early success of its first program focused in vasculitis.

Network (0)

There are no organizations in the network.

Recent activity

You are not connected

A certain number of contents are hidden from you and you do not benefit from the linking functionalities.

Log in or register to access to the entire contents and functionnalities. Subscription is quick and free.